In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory ...

Aragen Biologics launched CHOMax™, a new cell line development and early manufacturing platform that the company says supports an integrated path from DNA to IND-enabling clinical supply for suitable ...

For the last two years, the cultivated meat industry has been experiencing growing pains. Many startups have shrunk, shut ...

Electrode coating is the foundational and arguably most sensitive step in battery cell production. It involves the precise, ...

The discovery that tissues use electricity to expel unhealthy cells is part of a surge of renewed interest in the currents ...

The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...

RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and BOOST Pharma, a clinical-stage biotechnology company developing ...

Validated next-generation sequencing soon will become necessary in ensuring the safety and efficacy of cell and gene ...

Discover the top 3 manufacturing mistakes CDMOs make and how to prevent them when scaling for next-generation oncology.

Rescuing larvae from missile-damaged lab, Weizmann team finds cells that not only beat back death, but also multiply and spur ...

Company expects preliminary unaudited AUCATZYL® net product revenue of approximately $24 million for the fourth quarter of 2025 and approximately $75 million for the full year of 2025Autolus ...

Cellectis (the "Company") (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop ...